arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

MiMedx Group, Inc

MDXG Health Care Biotechnology: Pharmaceutical Preparations
$3.88
▲ +3.9% Today
as of Oct 23, 15:34 ET
Last 30 days -15.95% Sep 14 → Oct 23
$3.64 $3.99 $4.33 $4.68 $5.03 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.70
High
$4.03
Low
$3.67
Volume
$2M
Avg Vol
$1M
Mkt Cap
$672M
P/E (TTM)
—
Beta
—
52w High
$7.97
52w Low
$3.03
Div Yield
—
Shares Out
$146M

Recent Press Releases & News last 60 days · 5 items

▸ Show all 5 press releases & news Free account →

MDXG earnings at a glance

MiMedx Group, Inc (MDXG) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. The options market is pricing a move of about ±22.5% after the report, a range of roughly $3.01 to $4.75 from today's $3.88. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±6.2% on average; after the most recent report on Jul 29, 2026 it moved +0.9%. That means options currently expect more movement than MDXG has typically delivered. MDXG beat the consensus EPS estimate in 4 of its last 5 reported quarters. Implied volatility is currently 117%. The share price of $3.88 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.03
$7.97
17% of range
Avg surprise (last 5)
+53.0%
Avg reaction (last 6)
+1.4%
67% positive
Latest IV / EM
117%
EM ±22.5% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.07$-0.02$0.04$0.10$0.15 Actual $-0.06Actual $0.01Actual $0.06Actual $0.06Actual $0.12Actual $0.05Actual $0.06Est $0.06Actual $0.10Est $0.06Actual $0.15Est $0.07Actual $0.14Est $0.09Actual $-0.05Est $-0.07Actual $-0.05 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-15M$19M$52M$86M$119M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 29, 2026Jun/2026 $-0.05 — — — +0.9% earnings
Wed Apr 29, 20268K 2026-04-29 $-0.05 $-0.07 +28.6% — +8.7% earnings
Wed Feb 25, 20268K 2026-02-25 $0.14 $0.09 +55.6% — -6.4% earnings
Wed Oct 29, 2025Sep/2025 $0.15 $0.07 +114.3% — +2.9% earnings
Wed Jul 30, 2025Jun/2025 $0.10 $0.06 +66.7% — +10.3% earnings
Wed Apr 30, 2025Mar/2025 $0.06 $0.06 0.0% — -8.1% earnings
Mon Sep 30, 2024Sep 2024 $0.05 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.12 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.06 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.06 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.01 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.06 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER —$0.15

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$64M$59M—$114M$99M$88M—$84M
Cost of revenue$20M$17M—$19M$19M$17M—$15M
Gross profit$44M$42M—$95M$80M$72M—$69M
Operating income$-18M$-16M—$22M$12M$8M—$11M
Net income$-15M$-11M—$17M$10M$7M—$8M
EPS (diluted)$-0.10$-0.07—$0.11$0.06$0.05—$0.05

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$136M$160M$166M$142M$119M$106M$104M$89M
Inventory$21M$26M$25M$27M$25M$24M$24M$24M
Total current assets$205M$240M$277M$254M$221M$200M$192M$172M
Total assets$281M$309M$343M$319M$291M$270M$264M$244M
Long-term debt$16M$16M$16M$17M$17M$18M$18M$18M
Total liabilities$65M$66M$86M$80M$74M$68M$71M$63M
Total equity$216M$243M$257M$239M$217M$203M$193M$181M

Implied volatility — last 90 days

29%395%761%1126%1492% Jun 07 — IV 540% · EM ±74.9%Jun 09 — IV 534% · EM ±66.8%Jun 10 — IV 395% · EM ±46.7%Jun 11 — IV 601% · EM ±66.4%Jun 12 — IV 647% · EM ±66.2%Jun 15 — IV 977% · EM ±70.7%Jun 16 — IV 1196% · EM ±70.7%Jun 17 — IV 1492% · EM ±62.3%Jun 19 — IV 364% · EM ±80.4%Jun 24 — IV 332% · EM ±66.6%Jun 25 — IV 315% · EM ±61.7%Jun 29 — IV 325% · EM ±57.5%Jun 30 — IV 347% · EM ±59.7%Jul 01 — IV 361% · EM ±60.3%Jul 10 — IV 1068% · EM ±118.0%Jul 13 — IV 1453% · EM ±121.3%Jul 27 — IV 230% · EM ±48.1%Jul 31 — IV 247% · EM ±47.2%Aug 03 — IV 266% · EM ±47.2%Aug 04 — IV 224% · EM ±38.6%Aug 05 — IV 237% · EM ±39.7%Aug 10 — IV 837% · EM ±115.9%Aug 12 — IV 923% · EM ±115.7%Aug 13 — IV 302% · EM ±35.7%Aug 14 — IV 350% · EM ±38.6%Aug 19 — IV 514% · EM ±30.3%Aug 20 — IV 775% · EM ±32.4%Sep 21 — IV 35% · EM ±7.3%Sep 22 — IV 30% · EM ±6.1%Sep 25 — IV 117% · EM ±22.5%

Sector peers

MDXG earnings FAQ

When is MDXG's next earnings date?

MiMedx Group, Inc is expected to report on November 4, 2026.

What is MDXG's expected move for earnings?

Options currently price a move of about ±22.5%, or $0.87 per share either way from $3.88.

How does MDXG stock usually react to earnings?

Across the last 6 reports the average next-day move was ±6.2%, up 4 times and down 2 times.

What is MDXG's implied volatility?

MDXG's at-the-money implied volatility is about 117% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.